Promising results of captopril in improving knee arthrofibrosis and cartilage status: an animal model study
Abstract Purpose Several cytokines and growth factors start and progress the destruction process of joint hyaline cartilage and fibrosis formation. Captopril is classified as an Angiotensin‐converting enzyme inhibitor in which several studies revealed that captopril significantly decreases fibrosis...
Saved in:
| Main Authors: | Seyed Ali Hashemi, Ali Azad, Amirhossein Erfani, Reza Shahriarirad, Negar Azarpira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Experimental Orthopaedics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40634-022-00516-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors associated with arthrofibrosis-related revision following 14,325 total or unicompartmental knee arthro-plasties: an analysis from the Dutch Arthroplasty Registry
by: Myrthe P F van de Ven, et al.
Published: (2024-10-01) -
STUDY OF REOLOGICAL PROPERTIES OF CAPTOPRIL NASAL DOSAGE FORM
by: Аlmochаmаd Guмаа Аbdullах, et al.
Published: (2013-12-01) -
Therapeutic effect and underlying mechanism of low-intensity focused ultrasound on knee arthrofibrosis in rats
by: TANG Qiuyu, et al.
Published: (2025-06-01) -
Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence
by: Giuseppe Anzillotti, et al.
Published: (2024-10-01) -
Evaluation of the Hepatotoxicity Induced by Captopril and Enalapril in Rat Liver: A Comparative Study
by: Mohammed Ibrahim, et al.
Published: (2023-12-01)